Read the story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

CytoDyn Inc brings on Yahoo!, Shutterfly veteran law expert

% of readers think this story is Fact. Add your two cents.

CytoDyn Inc (OTCMKTS:CYDY) has added corporate law veteran Maura Fleming to its leadership team as vice president, general counsel and corporate secretary. 

Fleming joins the biotechnology company after serving as counsel for Holland & Hart LLP, where she provided legal expertise and contract management services to the food and beverage, technology, manufacturing and other industries.  

“We are excited to welcome Maura to the CytoDyn team,” CEO Nader Pourhassan said in a statement. “Her entrepreneurial spirit, broad legal background and experience in navigating the corporate life cycle strengthens our leadership team at this pivotal time. Maura will assist the CytoDyn team execute its goals as the Company continues to advance its targeted therapy, leronlimab, to address cancer, HIV and other autoimmune diseases.”

READ: CytoDyn’s impressive run continues for leronlimab in metastatic triple-negative breast cancer and metastatic breast cancer

Fleming has also held the role of senior corporate counsel at Shutterfly, was the director of legal services at Aerohive Networks Inc and began her career at Yahoo! Inc, where she spent seven years. 

All in all, she brings more than a decade of corporate transactional law experience.

“I am honored to join CytoDyn and look forward to leveraging my strategic and legal insight to advise the Company during this unprecedented period of extensive growth and evolution. I am eager to start working alongside the leadership team and support the continuing evolution of its corporate governance, transactions and other legal challenges.”

CytoDyn, based in Vancouver, Washington, is developing the drug candidate leronlimab to battle multiple diseases. The company has filed an Investigational New Drug (IND) application and a Phase 2 clinical trial protocol with the US Food and Drug Administration (FDA) for leronlimab to treat patients with NASH.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Story by ProactiveInvestors


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.